GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Gemina Laboratories Ltd (XCNQ:GLAB) » Definitions » Liabilities-to-Assets

Gemina Laboratories (XCNQ:GLAB) Liabilities-to-Assets : 2.55 (As of Apr. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Gemina Laboratories Liabilities-to-Assets?

Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities, calculated as total liabilities divided by total asset. Gemina Laboratories's Total Liabilities for the quarter that ended in Apr. 2024 was C$3.67 Mil. Gemina Laboratories's Total Assets for the quarter that ended in Apr. 2024 was C$1.44 Mil. Therefore, Gemina Laboratories's Liabilities-to-Assets Ratio for the quarter that ended in Apr. 2024 was 2.55.


Gemina Laboratories Liabilities-to-Assets Historical Data

The historical data trend for Gemina Laboratories's Liabilities-to-Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gemina Laboratories Liabilities-to-Assets Chart

Gemina Laboratories Annual Data
Trend Jan21 Jan22 Jan23 Jan24
Liabilities-to-Assets
0.94 0.34 1.04 2.09

Gemina Laboratories Quarterly Data
Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24
Liabilities-to-Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.49 0.95 1.40 2.09 2.55

Competitive Comparison of Gemina Laboratories's Liabilities-to-Assets

For the Biotechnology subindustry, Gemina Laboratories's Liabilities-to-Assets, along with its competitors' market caps and Liabilities-to-Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Gemina Laboratories's Liabilities-to-Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Gemina Laboratories's Liabilities-to-Assets distribution charts can be found below:

* The bar in red indicates where Gemina Laboratories's Liabilities-to-Assets falls into.



Gemina Laboratories Liabilities-to-Assets Calculation

Liabilities-to-Assets ratio measures the portion of the total liabilities to the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Liabilities-to-Assets ratio is calculated by dividing total liabilities by total asset.

Gemina Laboratories's Liabilities-to-Assets Ratio for the fiscal year that ended in Jan. 2024 is calculated as:

Liabilities-to-Assets (A: Jan. 2024 )=Total Liabilities/Total Assets
=3.041/1.456
=2.09

Gemina Laboratories's Liabilities-to-Assets Ratio for the quarter that ended in Apr. 2024 is calculated as

Liabilities-to-Assets (Q: Apr. 2024 )=Total Liabilities/Total Assets
=3.667/1.439
=2.55

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Gemina Laboratories  (XCNQ:GLAB) Liabilities-to-Assets Explanation

Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities. It can vary greatly across different industries, as they have different capital structure. A high Liabilities-to-Assets ratio (more leveraged) suggests that the company might have potential solvency problems, or even a signal of financial distress. Conversely, a low Liabilities-to-Assets ratio usually indicates a healthy financial situation. However, it may also suggest that the company is not expanding or not making good use of debt.


Gemina Laboratories Liabilities-to-Assets Related Terms

Thank you for viewing the detailed overview of Gemina Laboratories's Liabilities-to-Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Gemina Laboratories Business Description

Traded in Other Exchanges
Address
3800 Gilmore Mall, Suite 302, Burnaby, BC, CAN, V5G 4R8
Gemina Laboratories Ltd is a biotechnology company that operates in the In Vitro Diagnostics (IVD) market under the name Gemina Labs. The company endeavors to develop novel surface functionalization chemistries for the detection of pathogens and biomarkers.
Executives
James Damian Tansey Director

Gemina Laboratories Headlines

No Headlines